Life threatening symptoms of withdrawal of gamma-hydroxybutyrate;Levensbedreigende onthoudingsverschijnselen door gammahydroxyboterzuur

Tijdschrift voor Psychiatrie

Volumn 52, Issue 6, 2010, Pages 411-416

  Veerman, S R T ^a   Dijkstra, H N ^b   Liefting Kluft, I ^c  

^a GGZ InGeest   (Netherlands)

^b ZAANS MEDICAL CENTER   (Netherlands)

^c NONE   (Netherlands)

Author keywords

Clinical management; Dependence; Gamma hydroxybutyrate; Withdrawal

Indexed keywords

4 HYDROXYBUTYRIC ACID; BENZODIAZEPINE DERIVATIVE; SEDATIVE AGENT;

ACUTE PSYCHOSIS; AGITATION; ARTICLE; DRUG MEGADOSE; DRUG WITHDRAWAL; EXCITEMENT; HUMAN; PSYCHOSOMATICS; SIDE EFFECT; SYMPTOM;

ADULT; ANESTHETICS, INTRAVENOUS; HUMANS; MALE; SODIUM OXYBATE; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS;

EID: 77953792906     PISSN: 03037339     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Bissonnette, B., Swan, H., Ravussin, P., e.a. (1999). Neuroleptanesthesia: current status. Canadian Journal of Anesthesia, 46, 154-168.
2. Dyer, J.E., Roth, B., & Hyma, B.A. (2001). Gamma-hydroxybutyrate withdrawal syndrome. Annals of Emergency Medicine, 37,147-153.
3. Drasbek, K.R., Christensen, J., & Jensen, K. (2006). Gamma-hydroxybutyrate - a drug of abuse. Acta Neurologica Scandinavica, 114, 145-156.
4. Glasper, A., McDonough, M., & Beam, J. (2005). Within-patient variability in clinical presentation of gamma-hydroxybutyrate withdrawal: a case report. European Addiction Research, 11, 152-154. (Pubitemid 40910984)
5. Gorcum, T.F. van, van Velzen, A.G., van Riel, A.J.H.P., e.a. (2005). Acute vergiftigingen bij mens en dier: Jaaroverzicht 2004. Bilthoven: Nationaal Vergiftigingen Informatie Centrum.
6. Gorcum, T.F. van, van Velzen, A.G., & Brekelmans, P.J.A.M. (2008). Acute vergiftigingen bij mens en dier: Jaaroverzicht 2007. Bilthoven: Nationaal Vergiftigingen Informatie Centrum.
7. Kamal, R., van Hoek, A.F.M., de Haan, H.A., e.a. (2009). Stoppen met Gammahydroxybutyric acid (GHB), hoe doe je dat? In C.A.J. de Jong, B.J.M. van de Wetering & H.A. de Haan (Red.) Verslavingsgeneeskunde: Psychofarmacologie, psychiatrie en somatiek. Assen: Van Gorcum.
8. Lenz, D., Rothschild, M.A., & Kroner, L. (2008). Intoxications due to ingestion of gamma-butyrolactone: organ distribution of gamma-hydroxybutyric acid en gamma-butyrolactone. Therapeutic Drug Monitoring, 30,755-761.
9. Maxwell, J.C. (2003). The response to club drug use. Current Opinion in Psychiatry, 16, 279-289.
10. McDonough, N., Kennedy, A., & Glasper, J.B. (2004). Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review. Drug and Alcohol Dependence, 75, 3-9. (Pubitemid 38844572)
11. Stolte, E. (2009). GHB. Amsterdam: Stichting Consument en Veiligheid. http://www.hetccv.nl/binaries/content/assets/ccv/nieuws/2009/ GHB-ongevallencijfers.pdf
12. Miotto, K., & Roth, B. (2001). GHB withdrawal syndrome, Patients with a history of around-the-clock use of gamma hydroxybutyrate may present a disturbing and difficult to manage clinical picture. Austin: Texas Commission on Alcohol and Drug Abuse.
13. Raza, S.M.A., Masters, R.W., & Zsigmond, E.K. (1989). Haemodynamic stability with midazolam-ketamine-sufentanil analgesia in cardiac surgical patients. Canadian Journal of Anesthesia, 36, 617-623.
14. Reeves, J., & Duda, R. (2003). GHB/GBL intoxication and withdrawal: a review and case presentation. Addictive Disorders & Their Treatment, 2, 25-28.
15. Rij, C.M. van, van Loenen, A.C., & Wilhelm, A.J. (2004). Farmacotherapie. Herkenningen behandeling van hydroxyboterzuurintoxicaties. Nederlands Tijdschrift voor Geneeskunde, 148, 844-846.
16. Rosenberg, M.H., Deerfield, L.J., & Baruch, E.M. (2003). Two cases of severe gamma-hydroxybutyrate withdrawal delirium on a psychiatric unit: recommendations for management. The American Journal of Drug and Alcohol Abuse, 29, 487-496.
17. Tarabar, A.F., Nelson, L.S. (2004). The gamma-hydroxybutyrate withdrawal syndrome. GHB Symposium. The Toxicological Reviews, 23, 45-49.
18. Wojtowicz, J.M., Yarema, M.C., & Wax, P.M. (2008). Withdrawal from gamma-hydroxybutyrate, 1,4-butanediol and gamma-butyrolactone: a case report and systematic review. Canadian Journal of Emergency Medicine, 10, 69-74.
19. Zvosec, D.L., & Smith, S.W. (2005). Agitation is common in gamma-hydroxybutyrate toxicity. American Journal of Emergency Medicine, 23, 316-320.